MAIA Biotechnology, Inc. MAIA
Set alert
1.10 USD 0.00 0.00%
At close · Nov 2
1.15 +0.05 +4.26%
After hours · Nov 2, 4:00 PM ET
1.09 Day range 1.14
0.87 52-week range 3.19
- YTD
- -28.10%
- 1 year
- -11.29%
- Open
- 1.11
- Prev close
- 1.10
- Mkt cap
- 67.92M
- Vol
- 151.70K
- Avg vol
- 461.19K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.09
- High
- 1.14
- Forward P/E
- -1.25
- Beta
- 0.34
- Short ratio
- 10.99
- Inst. own
- 7.51%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.41
- 200-d avg
- 2.83
- 1y target
- 12.63
MAX chart
Events in this range
- Feb 21, 2023Rating: Noble Capital Markets · — → Outperform
Signals (76)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
Newest 20 of 76.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 12.63 +1047.7% upside
Now 1.10
- Target (low)
- 11.25
- Target (mean)
- 12.63
- Target (high)
- 14.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.35 | -0.50 – -0.20 | -0.4157 | +15.8% | 0 | 0.0% | 2 |
| Next quarter | -0.25 | -0.25 – -0.25 | -0.46 | +45.7% | 0 | 0.0% | 1 |
| Current year | -1.61 | -1.92 – -1.30 | -1.51 | -6.9% | 0 | 0.0% | 2 |
| Next year | -1.35 | -1.35 – -1.35 | -1.61 | +16.1% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 21, 2023 | Noble Capital Markets | Initiated | — | Outperform |